Key result
Higher cardiorespiratory fitness is linked to ~9% lower odds of high-risk hepatic steatosis per ml/kg/min.
Why the study?
Is higher objectively assessed cardiorespiratory fitness associated with lower odds of elevated non-invasive markers of hepatic steatosis and fibrosis in UK adults?
Cross-Sectional (n=39,197)
Yes
Is higher objectively assessed cardiorespiratory fitness associated with lower odds of elevated non-invasive markers of hepatic steatosis and fibrosis in UK adults?
Answers are grounded in this paper and cite their sources.
Higher objectively measured cardiorespiratory fitness is independently associated with lower odds of both hepatic steatosis and hepatic fibrosis across four validated non-invasive indices in 39,197 UK adults, supporting fitness as an integrative biomarker and modifiable target in steatotic liver disease.
Cardiorespiratory fitness (CRF) is a powerful predictor of numerous health outcomes; however, its relationship with liver health remains unclear. This study examined the associations of CRF with non-invasive markers of liver steatosis and fibrosis in a large, health-screening cohort, and explored potential effect modification by demographic, cardiometabolic, and clinical factors. In this independent healthcare-based cross-sectional study of 39,197 UK adults (32% female; mean ± SD, age 45.8 ± 9.0 years), CRF was objectively estimated as peak oxygen uptake (ml∙kg −1 ∙min −1 ) during submaximal treadmill and cycle ergometer tests. Hepatic steatosis and fibrosis were defined using validated non-invasive indices: Fatty Liver Index (FLI) and Hepatic Steatosis Index (HSI) for steatosis, and Fibrosis-4 Index (FIB-4) and NAFLD Fibrosis Score (NFS) for fibrosis. Multinomial logistic regression examined associations between CRF and low-, intermediate-, and high-risk categories for each index, adjusting for demographic, cardiometabolic, and clinical covariates (excluding component variables of the respective indices). For FLI and HSI, each 1 ml∙kg −1 ∙min −1 higher CRF was associated with 3–5% lower odds of intermediate steatosis risk and 8–9% lower odds of high steatosis risk ( P < 0.001). For FIB-4 and NFS, higher CRF was associated with 1–3% lower odds of intermediate fibrosis risk and 2–6% lower odds of high fibrosis risk ( P ≤ 0.011). Associations were stronger in females and weaker in individuals with less favourable metabolic profiles. Higher CRF was associated with lower odds of hepatic steatosis and fibrosis across multiple validated non-invasive indices. These findings highlight CRF as an integrative biomarker of hepatic and cardiometabolic health, and modifiable target for steatotic liver disease prevention and management.
No takes yet. Share an insight, caveat, or question.
Willis et al. (2026) conducted a cross-sectional in Hepatic steatosis and fibrosis (steatotic liver disease risk) (n=39,197). Cardiorespiratory fitness (VO2peak per 1 ml/kg/min increment) vs. Low-risk liver index category (reference group in multinomial logistic regression) was evaluated on High-risk vs. low-risk hepatic steatosis defined by Fatty Liver Index (FLI ≥ 60 vs < 30) (OR 0.906, 95% CI 0.902–0.910, p=< 0.001). Each 1 ml/kg/min higher cardiorespiratory fitness was associated with 7.5%–9.4% lower odds of high-risk hepatic steatosis and 1.6%–5.7% lower odds of high-risk fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: